End-of-day quote
Taiwan S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
115
TWD
|
+1.77%
|
|
+2.68%
|
-2.95%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
28,438
|
25,188
|
27,974
|
24,492
|
27,510
|
26,697
|
Enterprise Value (EV)
1 |
28,977
|
26,078
|
28,936
|
24,273
|
27,732
|
25,709
|
P/E ratio
|
22
x
|
35.2
x
|
25.5
x
|
14.4
x
|
19.2
x
|
17.5
x
|
Yield
|
4.08%
|
2.58%
|
3.32%
|
4.74%
|
3.38%
|
5.13%
|
Capitalization / Revenue
|
3.77
x
|
4.7
x
|
3.58
x
|
2.34
x
|
3.31
x
|
3.17
x
|
EV / Revenue
|
3.84
x
|
4.86
x
|
3.71
x
|
2.32
x
|
3.33
x
|
3.06
x
|
EV / EBITDA
|
15.4
x
|
20.9
x
|
18.8
x
|
10.8
x
|
14
x
|
11
x
|
EV / FCF
|
28.1
x
|
28.6
x
|
24.8
x
|
10.2
x
|
49.6
x
|
17.5
x
|
FCF Yield
|
3.56%
|
3.49%
|
4.04%
|
9.79%
|
2.01%
|
5.71%
|
Price to Book
|
4.07
x
|
3.86
x
|
3.81
x
|
3.06
x
|
3.35
x
|
2.74
x
|
Nbr of stocks (in thousands)
|
232,150
|
232,150
|
232,150
|
232,150
|
232,150
|
232,150
|
Reference price
2 |
122.5
|
108.5
|
120.5
|
105.5
|
118.5
|
115.0
|
Announcement Date
|
3/18/20
|
2/23/21
|
2/24/22
|
2/20/23
|
2/27/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
7,542
|
5,364
|
7,810
|
10,460
|
8,318
|
8,415
|
EBITDA
1 |
1,878
|
1,246
|
1,536
|
2,247
|
1,985
|
2,331
|
EBIT
1 |
1,442
|
769.9
|
1,066
|
1,786
|
1,519
|
1,683
|
Operating Margin
|
19.12%
|
14.35%
|
13.66%
|
17.08%
|
18.27%
|
20%
|
Earnings before Tax (EBT)
1 |
1,595
|
851
|
1,310
|
2,078
|
1,733
|
1,870
|
Net income
1 |
1,293
|
716.9
|
1,098
|
1,703
|
1,436
|
1,543
|
Net margin
|
17.14%
|
13.37%
|
14.06%
|
16.28%
|
17.26%
|
18.34%
|
EPS
2 |
5.560
|
3.080
|
4.720
|
7.330
|
6.170
|
6.557
|
Free Cash Flow
1 |
1,032
|
910.5
|
1,168
|
2,377
|
558.8
|
1,468
|
FCF margin
|
13.68%
|
16.98%
|
14.96%
|
22.73%
|
6.72%
|
17.45%
|
FCF Conversion (EBITDA)
|
54.95%
|
73.08%
|
76.06%
|
105.81%
|
28.15%
|
62.98%
|
FCF Conversion (Net income)
|
79.82%
|
127.01%
|
106.34%
|
139.6%
|
38.92%
|
95.14%
|
Dividend per Share
2 |
5.000
|
2.800
|
4.000
|
5.000
|
4.000
|
5.900
|
Announcement Date
|
3/18/20
|
2/23/21
|
2/24/22
|
2/20/23
|
2/27/24
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
2,296
|
1,893
|
2,373
|
3,242
|
2,609
|
2,236
|
2,271
|
2,294
|
1,839
|
1,914
|
1,729
|
2,325
|
2,170
|
2,191
|
EBITDA
1 |
-
|
238.8
|
487.6
|
732.4
|
529.5
|
494.7
|
496.2
|
-
|
410.5
|
428.1
|
391.7
|
649
|
649
|
583
|
EBIT
1 |
371.1
|
127.2
|
377.3
|
620
|
413.3
|
375.8
|
379.6
|
532.7
|
294.2
|
312.9
|
277.5
|
553
|
409
|
410
|
Operating Margin
|
16.16%
|
6.72%
|
15.9%
|
19.12%
|
15.84%
|
16.81%
|
16.71%
|
23.22%
|
16%
|
16.35%
|
16.05%
|
23.78%
|
18.85%
|
18.71%
|
Earnings before Tax (EBT)
1 |
404.1
|
279.8
|
420.8
|
667.7
|
545.5
|
444.1
|
400
|
575.7
|
414.8
|
343
|
328.2
|
592
|
508
|
448
|
Net income
1 |
330
|
243.9
|
343.4
|
558.4
|
448.2
|
352.8
|
326.2
|
481.8
|
337.4
|
290.4
|
277.6
|
498
|
415
|
377
|
Net margin
|
14.37%
|
12.88%
|
14.47%
|
17.22%
|
17.18%
|
15.78%
|
14.36%
|
21.01%
|
18.35%
|
15.17%
|
16.05%
|
21.42%
|
19.12%
|
17.21%
|
EPS
2 |
1.420
|
1.050
|
1.480
|
2.410
|
1.930
|
1.510
|
1.400
|
2.080
|
1.450
|
1.250
|
1.190
|
2.100
|
1.750
|
1.590
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/1/21
|
2/24/22
|
5/5/22
|
8/1/22
|
11/1/22
|
2/20/23
|
5/2/23
|
8/1/23
|
11/1/23
|
2/27/24
|
4/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
539
|
890
|
962
|
-
|
223
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
219
|
-
|
988
|
Leverage (Debt/EBITDA)
|
0.2869
x
|
0.7144
x
|
0.6267
x
|
-
|
0.1122
x
|
-
|
Free Cash Flow
1 |
1,032
|
911
|
1,168
|
2,377
|
559
|
1,468
|
ROE (net income / shareholders' equity)
|
18.5%
|
10.6%
|
15.8%
|
22.2%
|
17.7%
|
20.5%
|
ROA (Net income/ Total Assets)
|
10.9%
|
6.04%
|
9.4%
|
14.8%
|
12.7%
|
13.5%
|
Assets
1 |
11,904
|
11,867
|
11,688
|
11,471
|
11,296
|
11,430
|
Book Value Per Share
2 |
30.10
|
28.10
|
31.70
|
34.40
|
35.40
|
42.00
|
Cash Flow per Share
2 |
-
|
4.380
|
5.910
|
11.30
|
4.760
|
9.030
|
Capex
1 |
510
|
109
|
207
|
252
|
549
|
279
|
Capex / Sales
|
6.76%
|
2.03%
|
2.65%
|
2.41%
|
6.59%
|
3.32%
|
Announcement Date
|
3/18/20
|
2/23/21
|
2/24/22
|
2/20/23
|
2/27/24
|
-
|
Average target price
128.5
TWD Spread / Average Target +11.74% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.95% | 804M | | +4.70% | 103B | | +2.40% | 65.6B | | +42.86% | 39.06B | | +16.96% | 37.58B | | +6.96% | 33.26B | | +7.89% | 19.22B | | +12.12% | 16.83B | | +12.08% | 15.03B | | +17.69% | 14.96B |
Other Commodity Chemicals
|